Condition: Neutral Lipid Storage Disease · Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
This study aims to understand the state of onset of NLSD(neutral lipid storage disease) / TGCV(triglyceride deposit cardiovasculopathy) worldwide, background information of affected patients, and natural history of the disease, as well as exploring the prognostic factors and assessing the efficacy of disease-specific treatment.
This description comes directly from the study's public registry record.
Kenichi Hirano, MD, Ph.D · +81-6-6872-8215
Always discuss trial participation with your own doctor first.
| Stanford University | Stanford, California, United States | Recruiting |
| Columbia University | New York, New York, United States | Recruiting |
| University of Graz | Graz, Styria, Austria | Recruiting |
| Peking University First Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Pitié-Salpêtrière Hospital | Paris, Paris, France | Recruiting |
| Ludwig-Maximilians University | Munich, Bavaria, Germany | Recruiting |
| Sapienza University of Rome | Rome, Lazio, Italy | Recruiting |
| A.C.O. San Filippo Neri Hospital | Rome, Lazio, Italy | Recruiting |
| Catholic University | Milan, Lombardy, Italy | Recruiting |
| University of Padova | Padova, Veneto, Italy | Recruiting |
| Graduate School of Osaka University | Suita, Osaka, Japan | Recruiting |
| National Center of Neurology and Psychiatry | Kodaira, Tokyo, Japan | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02918032